Comparative Effectiveness of Single vs Repeated Rapid SARS-CoV-2 Antigen Testing Among Asymptomatic Individuals in a Workplace Setting

Bradley A Connor; Marina Rogova; Jefferson Garcia; Darshan Patel; Mara Couto-Rodriguez; Dorottya Nagy-Szakal; Michael Rendel

doi:10.1001/jamanetworkopen.2022.3073

Comparative Effectiveness of Single vs Repeated Rapid SARS-CoV-2 Antigen Testing Among Asymptomatic Individuals in a Workplace Setting

JAMA Netw Open. 2022 Mar 1;5(3):e223073. doi: 10.1001/jamanetworkopen.2022.3073.

Authors

Bradley A Connor^{1

2}, Marina Rogova², Jefferson Garcia², Darshan Patel³, Mara Couto-Rodriguez⁴, Dorottya Nagy-Szakal^{4

5}, Michael Rendel^{6

7}

Affiliations

¹ Weill Cornell Medicine, New York, New York.
² The New York Center for Travel and Tropical Medicine, New York.
³ The Reed Group, New York, New York.
⁴ Biotia, Inc, New York, New York.
⁵ Department Cell Biology, College of Medicine, SUNY Downstate Health Sciences University, New York, New York.
⁶ Mount Sinai School of Medicine, New York, New York.
⁷ Goldman Sachs Group Inc, New York, New York.

Abstract

This comparative effectiveness research study assesses the accuracy of single vs repeated antigen testing for diagnosis of COVID-19 among asymptomatic individuals in a workplace setting.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Serological Testing*
COVID-19* / diagnosis
Humans
SARS-CoV-2
Workplace